BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
BHVN
Delisted
BHVN was delisted on the 3rd of October, 2022.
240 hedge funds and large institutions have $8.78B invested in Biohaven Pharmaceutical Holding Company Ltd. in 2022 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 85 increasing their positions, 96 reducing their positions, and 115 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
27% less funds holding
Funds holding: 328 → 240 (-88)
75% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 115
Holders
240
Holding in Top 10
32
Calls
$596M
Puts
$265M
Top Buyers
| 1 | +$404M | |
| 2 | +$273M | |
| 3 | +$173M | |
| 4 |
GCL
Glazer Capital LLC
New York
|
+$151M |
| 5 |
SFM
Soros Fund Management
New York
|
+$151M |
Top Sellers
| 1 | -$283M | |
| 2 | -$267M | |
| 3 | -$181M | |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$165M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$108M |